Name: | Description: | Size: | Format: | |
---|---|---|---|---|
173.47 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Neurotransmitter diseases are a group of inherited disorders attributable
to a disturbance of neurotransmitter metabolism. Biogenic amines are neurotransmitters with multiple roles including psychomotor function, hormone secretion, cardiovascular, respiratory and gastrointestinal control, sleep mechanisms, body temperature and pain.
Given the multiple functions of monoamines, disorders of their metabolism comprise a
wide spectrum of manifestations, with motor dysfunction being the most prominent
clinical feature.
Methods: Case review of 12 patients from 4 families, with primary disorders of
biogenic amine metabolism.
Results: Aromatic L-amino acid decarboxylase deficiency (4 patients from 2 families),
and GTP-cyclohydrolase (8 patients from 2 families) were the two diseases identified.
Age at first symptoms varied between 2 months and 6 years. Developmental delay was
present in all cases except 2 patients with GTP cyclohydrolase deficiency. The
combination of axial hypotonia and limb dystonia was also frequent. Children with
aromatic L-amino acid decarboxylase deficiency exhibited temperature instability,
oculogyric crisis and disturbances of sleep. The index case of one family with GTP
cyclohydrolase deficiency presented with Parkinsonism (bradykinesia, rigidity and
hypomimia). Analysis of neurotransmitters and their metabolites in CSF was crucial for
the identification of index cases. Response to therapy was variable but in general
unsatisfactory except in a family with GTP cyclohydrolase deficiency.
Conclusions: These disorders should be considered in the differential diagnosis of
paediatric neurodegenerative diseases, in order to allow an adequate therapeutic trial
that can favor prognosis.
Description
Keywords
Doenças Neurotransmissoras Caso Clínico HDE NEU PED HDE MTB
Citation
IN: The 9th European Pediatric Neurology Society (EPNS) Congress; 2011 10-14 Maio. Cavtat, Croácia
Publisher
Serviço de Neuropediatria e Unidade de Doenças Metabólicas, Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central, EPE